Streptonigrin was first isolated from Streptomyces flocculus as an antitumor antibiotici;). Later, the antibiotic was recognized to be a potent inhibitor of avian myeloblastosis virus (AMV) reverse transcriptase2).
Recently, we reported that streptonigrin inhibited AMV reverse transcriptase mainly by interacting with an enzyme molecule3). According to the results of the kinetic analysis, streptonigrin inhibited reverse transcriptase in a non-competitive manner. As reported previously4~6), the cytotoxicity of streptonigrin results in part from its bypassing effect on the mitochondrial oxidative phosphorylation.
In the presence of catalytic amounts of streptonigrin, DT-diaphorase catalyzes the oxidation of NADHsupplied by the mitochondrial redox system. The hydroquinone of streptonigrin formed in conjunction with the oxidation of NADH in turn autoxidizes to the quinone by transferring electrons to molecular oxygen. The electron-acceptor activity of streptonigrin was also observed in the oxidation of NADH by Clostridium kluyveri diaphorase6).
Like streptonigrin, sakyomicin A is a quinone antibiotic with an inhibitory activity against reverse transcriptase7» 8) , The semiquinone which results from the addition of single-electron to the quinone or loss of an electron from the quinol may act either as an oxidizing or reducing agent with transfer of its electron to substrate or acceptance of a second electron with formation of a quinol or quinone, respectively.
As described above, both sakyomicin A and streptonigrin were active as electron acceptors in the oxidation of NADH by C. kluyveri diaphorase. The activity was determined by an amount of hydrogen peroxide which was generated by either two-electron or single-electron reduction of molecular oxygen. The former probably results from the donation of two electrons from the autoxidizing hydroquinone to molecular oxygen, and in the latter case, the semiquinone may exist as an intermediate which accepts a single-electron from NADH and donates an electron to molecular oxygen, resulting in the generation of superoxide anion (O2~). In terms of the specific activity in the inhibition of reverse transcriptase, streptonigrin was 10-fold more active than sakyomicin A; the ID50 values were 51^m for sakyomicin A and 5.9^m for streptonigrin.
It seemed to be interesting to compare the contributions of twoelectron and single-electron reductions of molecular oxygen to the generation of hydrogen peroxide, in other words, the one-electron reduction potential of individual antibiotics and quinones.
Ferricytochrome c (horse heart, Type III), catalase (bovine liver, EC 1.ll.1.6) and NADH were purchased from Sigma Chemical Co. The results shown in Fig. 3 indicate that the putative redox cycle of the antibiotics does not affect significantly the enzyme inhibitory activities of the antibiotics.
According to the findings of Wick and Fitzgerald, no inhibition of reverse transcriptase was observed in the absence of dithiothreitol (DTT) in the reaction mixture, suggesting that DTT-dependent reduction of quinones might be prerequisite for the inhibition of reverse transcriptase.
However, our results did not support their proposition (Fig. 4) . The standard assay was conducted in the presence of 2.5 mMDTT. Whenthe concentration of DTTwas as low as 0.001 mM,the inhibition of reverse transcriptase by 3^g/ml streptonigrin decreased to ca. 40% from 70-80% observed at the higher DTT concentrations (0.03-3.0 mM). However, it should be noted that the activity without any inhibitor was also depressed significantly (approximately 30 % the maximum value) at 0.001 mMDTT.
Taken together, these observations lead to the conclusion that the single-electron reduction potential and the generation of semiquinone and/or oxygen radical did not determine the inhibitory activities of these antibiotics against reverse transcriptase, in contrast to the earlier postulated mechanism proposed by Wick and Fitzgerald10 depending on one-electron reactions and generation of radicals.
However, we could not exclude the possible involvement of another oxidation-reduction process in the inhibition of reverse transcriptase. 
